(S)-4-((8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)methyl)benzoic acid

ID: ALA4210773

PubChem CID: 132213680

Max Phase: Preclinical

Molecular Formula: C23H18ClN3O4

Molecular Weight: 435.87

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(CN2C(=O)c3ccc(Cl)cc3NC(=O)[C@@H]2Cc2ccccn2)cc1

Standard InChI:  InChI=1S/C23H18ClN3O4/c24-16-8-9-18-19(11-16)26-21(28)20(12-17-3-1-2-10-25-17)27(22(18)29)13-14-4-6-15(7-5-14)23(30)31/h1-11,20H,12-13H2,(H,26,28)(H,30,31)/t20-/m0/s1

Standard InChI Key:  JSFGGWBJZGWYEV-FQEVSTJZSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   11.0480  -12.1976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8465  -10.8452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9595  -14.3785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2015  -10.3308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7725   -9.5058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8337   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0767  -13.4876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4739  -15.0235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7725  -10.3308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2462  -10.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4837  -11.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1437  -14.5015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8465   -8.9914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8638  -12.0746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0712  -12.0617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0580   -9.0933    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.2462  -12.0617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0087   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3781  -12.7196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1652   -8.5300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8337  -11.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6508   -9.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2015   -9.5058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4870   -9.0933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6508  -10.6616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0712  -10.6328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2609  -13.6105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1652  -11.3066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6629  -11.6495    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4870  -10.7433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7466  -12.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9 30  1  0
 11 26  2  0
 22 20  2  0
 14 19  2  0
  2 25  1  0
  4  2  1  0
 17 15  2  0
  6 10  1  0
  3 12  1  0
  5  9  2  0
 26 10  1  0
 13 22  1  0
 18  6  1  6
 15 11  1  0
 27  3  1  0
  2 29  2  0
 31  1  2  0
 23 24  2  0
  5 16  1  0
 23 13  1  0
  4 23  1  0
 25 28  1  0
  7 27  2  0
 21 17  1  0
 10 21  2  0
  3  8  2  0
 19  7  1  0
 25 18  1  0
 22 18  1  0
 24  5  1  0
 27 31  1  0
  1 14  1  0
 30  4  2  0
 28 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4210773

    ---

Associated Targets(non-human)

tcdB Toxin B (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridioides difficile (2968 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Limosilactobacillus reuteri (118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bifidobacterium longum (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides fragilis (1445 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.87Molecular Weight (Monoisotopic): 435.0986AlogP: 3.64#Rotatable Bonds: 5
Polar Surface Area: 99.60Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.94CX Basic pKa: 4.65CX LogP: 3.05CX LogD: 0.78
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.64Np Likeness Score: -0.89

References

1. Letourneau JJ, Stroke IL, Hilbert DW, Sturzenbecker LJ, Marinelli BA, Quintero JG, Sabalski J, Ma L, Diller DJ, Stein PD, Webb ML..  (2018)  Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).,  28  (4): [PMID:29331267] [10.1016/j.bmcl.2018.01.005]

Source